It was reported during an amsect perfusion meeting that the rotaflow flow sensor is losing its capabilities.This affected the displayed flow on the device.The failure occurred during patient treatment.The customer renewed the ultrasonic contact cream and restarted the device to solve the problem.No harm to any person occurred.A service technician was on site on 2022-05-17 to check the affected rotaflow (serial# (b)(6).The technician confirmed the reported failure, since the customer was not renewing the ultrasonic contact cream after 48h as described in the instruciton for use (see below).This led to the reported loss of the displayed flow on the device.No malfunction was detected and the device is working as intended.Based on these investigation results the reported failure could be confirmed.The most probable root cause could be determined as dried contact cream, since the user did not renew it.The product in question was produced in 2020-01-08.The review of the non-conformities has been performed on 2022-05-24 for the period of 2020-01-08 to 2022-04-08.It does not show any non-conformity in regard to the reported product and failure.There is no indication on manufacturing issues occurred during this time, thus production related influences are unlikely.In order to avoid reoccurrence of the reported failure, the customer was informed by the getinge sales and service unit (ssu) to follow the chapter in the instruction for use heart-lung support system rotaflow system| 4.4 | en | 15.Chapter 2.2.4 general precautionary measures during use/ 6.2 reapplying ultrasonic contact cream.The ultrasonic contact cream can dry out and impair the functioning of the integrated flow/bubble sensor.In the "free" mode, the ultrasonic contact cream must be reapplied every 48 hours or as soon as the error message [sig!] appears.In the "stand al" mode, the ultrasonic contact cream must be reapplied every 48 hours or as soon as the error message [faultbub] appears.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse trending.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required.
|